ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #872Top JournalReview JournalHybrid

Autoimmunity Reviews

Abbreviation (ISO):AUTOIMMUN REV
•
Identifier (ISSN):1568-9972(Print)/1873-0183(Online)
•
Publisher:Elsevier
Clarivate IF (2026)
9.8↑ +1.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Autoimmunity Reviews

WoS Q1
51117238.7420187.7220197.7720209.75202117.4202213.620239.220248.320259.82026
Annual Impact Factor Metric
Current (2026):9.8
Scopus SJR & RankScopus Q1
2.669
#872

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
170

170 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate4.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
106articles/year
32.24% Gold OA•28.68% Original Research

Aims & Scope

Autoimmunity Reviews will publish up-to-date, structured reviews on diverse topics in autoimmunity, written by first-class experts in the field. The articles will include demonstrative illustrations and tables and will all have a "take-home" message. Articles will principally be invited by the Editors-in-Chief upon the recommendations of the international Editorial Board, and will cover all fields of autoimmunology, bridging the gap between basic and clinical sciences. Contributions in basic sciences will include those on the pathophysiology and mechanisms of disorders as well as genomics and proteomics; clinical contributions will focus upon the diseases, novel therapies and clinical associations.

Topics Covered (Recognized by AI)
Medicine96.7%Biology93.1%Internal medicine89.9%Immunology85.9%Pathology81.5%Genetics79.2%Disease66.4%Antibody59%Immune system40.7%Chemistry40.7%Biochemistry38.8%Psychology30.7%Psychiatry27.2%Surgery25.9%Autoimmunity24.8%Endocrinology22.9%Autoantibody20.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q1
Rank18/183
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q1
Rank19/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF9.8
Articles / Year148
Total Citations84
2025
IF8.3
Articles / Year165
Total Citations1,308
2024
IF9.2
Articles / Year146
Total Citations2,157
2023
IF13.6
Articles / Year170
Total Citations4,769
2022
IF17.39
Articles / Year148
Total Citations4,116

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #872Scopus Q1SCImago Profile
Scopus Coverage:2002-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
2.669

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
9.52

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,020 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,906
3-Year Documents427
Citable Documents360

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1
Immunology and AllergyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Autoimmunity Reviews (abbr: AUTOIMMUN REV, ISSN: 1568-9972) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in United States since 2002. The periodical holds a Journal Impact Factor (JIF) of 9.80, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.669 (Q1), an H-index of 170.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 106 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,020 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier
Publication Language
English
Frequency
Bimonthly
Founding Year
2002
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 42844f7d-be2a-4f2d-9e2a-77e2c19ca33b
Database Updated: 2026-10-16